New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Enanta Pharmaceuticals, Inc. (ENTA) vs Rocket Pharmaceuticals, Inc. (RCKT)
- Enanta Pharmaceuticals, Inc. ENTA 7.62 −4.51%
- Rocket Pharmaceuticals, Inc. RCKT 1.95 −7.58%
Enanta Pharmaceuticals, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($235.6M and $232.7M). Across the 10 metrics below, Rocket Pharmaceuticals, Inc. leads on 6 and Enanta Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | ENTA | RCKT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (99.01%) | — | 0.00% |
| Net margin | (108.33%) | — | 0.00% |
| Free cash flow margin | (67.88%) | — | 0.00% |
| Return on equity | (94.19%) | (5.04%) | (51.58%) |
| Return on assets | (24.54%) | (4.10%) | (45.91%) |
| Return on invested capital | 0.00% | (111.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack